HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights

    NEXT STORY
    Guardant Health, Inc. Announces Proposed Public Offering of Common Stock
    PREV STORY
    AzurRx BioPharma Presents Positive Secondary Endpoint Data in its Phase II MS1819-SD Chronic Pancreatitis Study at the 2019 Digestive Disease Week Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Doctors Fear Coming Flu Season Plus COVID-19 Will Overwhelm Hospitals; RxAir UV Light Air Purifier Helps by Reducing Risk of Airborne Viral Infections

    author_avatar
    NASDAQ Market News

    Chembio to Present Today at the Rodman & Renshaw 18th Annual Global Investment Conference

    MEDFORD, N.Y., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

    author_avatar
    NASDAQ Market News

    AB Science communicates the results from phase 2B/3 study evaluating masitinib in Alzheimer’s disease

    author_avatar
    NASDAQ Market News